Moderna (MRNA)
79.51
+0.23 (0.29%)
Upcoming Events
Latest Headlines
Moderna (MRNA) call put ratio 1.9 calls to 1 put into investor meeting
September 11, 2024 4:34 AM - StreetInsider
Form 4 Moderna, Inc. For: Sep 06 Filed by: Klinger Shannon Thyme
September 10, 2024 4:15 PM - SEC Filing
Carisma Therapeutics (CARM) and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
September 10, 2024 7:31 AM - StreetInsider
Carisma and Moderna Expand Collaboration to Develop Two In Vivo CAR-M Therapies for Autoimmune Diseases
September 10, 2024 7:30 AM - PR NewsWire
Moderna (MRNA) option implied volatility elevated into investor meeting
September 10, 2024 5:21 AM - StreetInsider
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
September 9, 2024 3:30 PM - SEC Filing
Moderna's (MRNA) Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
September 9, 2024 7:32 AM - StreetInsider
Moderna’s Canadian Manufacturing Facility Receives Drug Establishment License From Health Canada
September 9, 2024 7:32 AM - StreetInsider
Moderna (MRNA) option implied volatility near upper end of range into investor meeting
September 9, 2024 5:14 AM - StreetInsider
Moderna (MRNA) Reports EMA CHMP's Positive Opinion of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
September 5, 2024 8:04 AM - StreetInsider
EMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
September 5, 2024 8:04 AM - StreetInsider
Form 4 Moderna, Inc. For: Aug 30 Filed by: Klinger Shannon Thyme
September 4, 2024 5:42 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 30 Filed by: Hoge Stephen
September 4, 2024 4:35 PM - SEC Filing
Moderna (MRNA) call put ratio 2.6 calls to 1 put with focus on September 6 weekly 77 calls
September 4, 2024 11:22 AM - StreetInsider
Moderna's (MRNA) experimental mpox vaccine reduces severity of disease, early study finds - DJ
September 4, 2024 11:03 AM - StreetInsider
Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031
September 4, 2024 8:30 AM - StreetInsider
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
September 3, 2024 3:58 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Hoge Stephen
September 3, 2024 3:43 PM - SEC Filing
Moderna (MRNA) Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
September 3, 2024 8:34 AM - StreetInsider
Moderna Receives Medicines And Healthcare Products Regulatory Agency (MHRA) Authorization For Updated COVID-19 Vaccine Targeting SARS-COV-2 Variant JN.1
September 3, 2024 8:34 AM - StreetInsider
Moderna (MRNA) Announces Taiwanese Approval of its COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
September 3, 2024 6:14 AM - StreetInsider
Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA)
September 3, 2024 5:27 AM - StreetInsider
Taiwan Food & Drug Administration Approves Moderna’s COVID-19 mRNA Vaccine Targeting the SARS-COV-2 Variant JN.1
September 2, 2024 7:02 AM - StreetInsider
Form 4 Moderna, Inc. For: Aug 28 Filed by: Mock James M
August 30, 2024 4:38 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 28 Filed by: Klinger Shannon Thyme
August 30, 2024 4:35 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 28 Filed by: Hoge Stephen
August 30, 2024 4:33 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 27 Filed by: Mock James M
August 29, 2024 4:46 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 27 Filed by: Klinger Shannon Thyme
August 29, 2024 4:04 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
August 29, 2024 3:53 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Mock James M
August 29, 2024 3:44 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Hoge Stephen
August 29, 2024 3:38 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Mock James M
August 28, 2024 4:48 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Klinger Shannon Thyme
August 28, 2024 4:30 PM - SEC Filing
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
August 28, 2024 6:30 AM - PR NewsWire
HSBC Upgrades Moderna (MRNA) to Hold
August 28, 2024 5:12 AM - StreetInsider
Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
August 23, 2024 8:20 AM - StreetInsider
Brookline Capital Markets Reiterates Buy Rating on Moderna (MRNA)
August 23, 2024 7:50 AM - StreetInsider
Moderna (MRNA) Receives European Commission Approval for RSV Vaccine mRESVIA(R)
August 23, 2024 7:03 AM - StreetInsider
Moderna Receives European Commission Approval for RSV Vaccine mRESVIA(R)
August 23, 2024 7:02 AM - StreetInsider
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna's COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
August 23, 2024 1:26 AM - StreetInsider
Moderna (MRNA) Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
August 22, 2024 1:59 PM - StreetInsider
US FDA approves updated COVID shots ahead of fall and winter
August 22, 2024 1:50 PM - StreetInsider
Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccine Targeting KP.2 Variant of SARS-CoV-2
August 22, 2024 1:48 PM - StreetInsider
Moderna to Host Investor Event - R&D Day and Business Updates
August 22, 2024 7:03 AM - StreetInsider
Moderna stock: What could trigger a turnaround over the next 3-6 months?
August 15, 2024 7:00 PM - StreetInsider
Moderna (MRNA) PT Lowered to $88 at JPMorgan
August 15, 2024 7:10 AM - StreetInsider
Moderna and Coursera Launch Free Course on mRNA Technology
August 14, 2024 7:02 AM - StreetInsider
Form 4 Moderna, Inc. For: Aug 09 Filed by: Hoge Stephen
August 13, 2024 4:34 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Hoge Stephen
August 12, 2024 4:06 PM - SEC Filing
Form 4 Moderna, Inc. For: Aug 05 Filed by: Rubenstein David M.
August 7, 2024 4:07 PM - SEC Filing
Form 3 Moderna, Inc. For: Aug 05 Filed by: Rubenstein David M.
August 7, 2024 4:03 PM - SEC Filing
Deutsche Bank Upgrades Moderna (MRNA) to Hold, 'a more troublesome Winter’s Tale, but up to Hold'
August 6, 2024 4:18 PM - StreetInsider
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner
August 6, 2024 6:30 AM - PR NewsWire
Midday movers: Apple, Nvidia, Intel, Coinbase and Moderna fall
August 5, 2024 7:35 AM - StreetInsider
Moderna plunges on downgrade amid vaccine headwinds
August 5, 2024 7:04 AM - StreetInsider
RBC Capital Downgrades Moderna (MRNA) to Sector Perform
August 5, 2024 5:11 AM - StreetInsider
Form 4 Moderna, Inc. For: Jul 31 Filed by: AFEYAN NOUBAR
August 2, 2024 7:00 PM - SEC Filing
Moderna (MRNA) PT Lowered to $94 at Morgan Stanley
August 2, 2024 9:18 AM - StreetInsider
Moderna (MRNA) PT Lowered to $140 at UBS
August 2, 2024 8:49 AM - StreetInsider
Moderna (MRNA) PT Lowered to $157 at Piper Sandler
August 2, 2024 7:40 AM - StreetInsider
Moderna (MRNA) PT Lowered to $178 at Goldman Sachs
August 2, 2024 6:32 AM - StreetInsider
Moderna (MRNA) PT Lowered to $125 at RBC Capital
August 2, 2024 6:31 AM - StreetInsider
Moderna (MRNA) PT Lowered to $155 at Barclays
August 2, 2024 6:02 AM - StreetInsider
Form 10-Q Moderna, Inc. For: Jun 30
August 1, 2024 4:03 PM - SEC Filing
Moderna (MRNA) PT Lowered to $120 at Jefferies
August 1, 2024 3:59 PM - StreetInsider
Midday movers: Meta Platforms, Lilly rise; Arm, Moderna fall
August 1, 2024 8:07 AM - StreetInsider
Moderna stock plunges as guidance cut on low EU sales, U.S. vaccine competition
August 1, 2024 6:52 AM - StreetInsider
Moderna (MRNA) Tops Q2 EPS by 2c; cuts revenue guidance
August 1, 2024 6:35 AM - StreetInsider
Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 1, 2024 6:33 AM - StreetInsider
Moderna cuts 2024 sales forecast, sees low EU vaccine revenue into 2026
August 1, 2024 6:32 AM - StreetInsider
Form 8-K Moderna, Inc. For: Aug 01
August 1, 2024 6:32 AM - SEC Filing
At least 3 killed in Nigeria at protests over high cost of living
August 1, 2024 6:30 AM - StreetInsider
Fed guidance, BOE, Meta's results, Apple - what's moving markets
August 1, 2024 5:47 AM - StreetInsider
Stocks expected to have increasing option volume: MRNA HSY RBLX K LH WEN SHAK RDDT
August 1, 2024 5:34 AM - StreetInsider
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
July 31, 2024 4:20 PM - SEC Filing
Moderna (MRNA) August weekly option IV elevated into quarter results
July 31, 2024 11:15 AM - StreetInsider
Moderna (MRNA) August 2 weekly 120 straddle priced into quarter results
July 31, 2024 5:01 AM - StreetInsider
GSK (GSK) and Flagship Pioneering partner to discover novel medicines and vaccines
July 29, 2024 7:04 AM - StreetInsider
GSK and Flagship Pioneering partner to discover novel medicines and vaccines
July 29, 2024 7:00 AM - PR NewsWire
Form 4 Moderna, Inc. For: Jul 24 Filed by: AFEYAN NOUBAR
July 26, 2024 7:00 PM - SEC Filing
Analog Devices and Flagship Pioneering Announce Strategic Partnership to Accelerate the Development of a Fully Digitized Biological World
July 25, 2024 8:00 AM - PR NewsWire
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
July 24, 2024 4:19 PM - SEC Filing
Moderna (MRNA) Appoints David Rubenstein to its Board
July 23, 2024 10:35 AM - StreetInsider
David Rubenstein Joins Moderna's Board of Directors
July 23, 2024 10:34 AM - StreetInsider
Moderna (MRNA) Announces Resignations of Robert Langer and Stephen Berenson from Board
July 23, 2024 7:14 AM - StreetInsider
Form 8-K Moderna, Inc. For: Jul 19
July 23, 2024 7:06 AM - SEC Filing
Flagship Pioneering Unveils Abiologics to Pioneer Supranatural Biologics, A New Biotherapeutic Class
July 23, 2024 6:00 AM - PR NewsWire
Form 4 Moderna, Inc. For: Jul 17 Filed by: AFEYAN NOUBAR
July 19, 2024 7:00 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
July 17, 2024 4:24 PM - SEC Filing
Alltrna Announces Updates to Its Board of Directors
July 17, 2024 8:00 AM - PR NewsWire
Form 4 Moderna, Inc. For: Jul 15 Filed by: Hoge Stephen
July 16, 2024 4:08 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Hoge Stephen
July 15, 2024 11:45 AM - SEC Filing
Form 4 Moderna, Inc. For: Jul 10 Filed by: AFEYAN NOUBAR
July 12, 2024 7:00 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
July 10, 2024 4:20 PM - SEC Filing
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
July 10, 2024 7:01 AM - StreetInsider
Flagship Pioneering Expands Leadership Team with Key Appointments and Promotions
July 10, 2024 6:00 AM - PR NewsWire
Flagship Pioneering Raises $3.6 Billion to Fuel Breakthrough Innovations that Transform Human Health and Sustainability
July 10, 2024 6:00 AM - PR NewsWire
Form 4 Moderna, Inc. For: Jul 05 Filed by: Mock James M
July 9, 2024 4:35 PM - SEC Filing
Moderna (MRNA) Partners with Mitsubishi Tanabe Pharma to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
July 9, 2024 5:41 AM - StreetInsider
Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
July 8, 2024 7:02 PM - StreetInsider
Form 144 Moderna, Inc. Filed by: Mock James M
July 8, 2024 3:28 PM - SEC Filing
Moderna (MRNA) option IV flat into quarter results
July 3, 2024 5:22 AM - StreetInsider
Moderna (MRNA) Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
July 2, 2024 7:31 AM - StreetInsider
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
July 2, 2024 7:31 AM - StreetInsider
US Inks Vaccine Deal With Moderna (MRNA) as Bird Flu Threat Looms - Bloomberg
July 2, 2024 7:01 AM - StreetInsider
Form 4 Moderna, Inc. For: Jun 26 Filed by: AFEYAN NOUBAR
June 28, 2024 7:00 PM - SEC Filing
Midday movers: Nike and Accolade fall; Humana and Infinera rise
June 28, 2024 7:49 AM - StreetInsider
Moderna (MRNA) Reports Positive EMA Opinion Recommending Marketing Authorization of mRESVIA
June 28, 2024 7:02 AM - StreetInsider
EMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
June 28, 2024 7:02 AM - StreetInsider
TD Cowen Reiterates Hold Rating on Moderna (MRNA)
June 27, 2024 12:31 PM - StreetInsider
Moderna (MRNA) July 5 weekly 116 puts and July 125 puts active amid wide price movement
June 27, 2024 11:28 AM - StreetInsider
Piper Sandler Reiterates Overweight Rating on Moderna (MRNA)
June 27, 2024 7:53 AM - StreetInsider
Moderna shares decline, RSV vaccine efficacy lags behind competitors
June 26, 2024 4:38 PM - StreetInsider
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
June 26, 2024 4:19 PM - SEC Filing
Jefferies Reiterates Buy Rating on Moderna (MRNA)
June 26, 2024 10:34 AM - StreetInsider
Moderna (MRNA) sees heavy early weakness amid CDC presentation
June 26, 2024 10:08 AM - StreetInsider
Form 4 Moderna, Inc. For: Jun 18 Filed by: AFEYAN NOUBAR
June 21, 2024 7:00 PM - SEC Filing
Moderna (MRNA) PT Raised to $150 at Argus
June 20, 2024 2:31 PM - StreetInsider
Form 144 Moderna, Inc. Filed by: AFEYAN NOUBAR
June 18, 2024 4:28 PM - SEC Filing
Form 4 Moderna, Inc. For: Jun 17 Filed by: Hoge Stephen
June 18, 2024 4:06 PM - SEC Filing
Form 4 Moderna, Inc. For: Jun 14 Filed by: Bancel Stephane
June 17, 2024 4:12 PM - SEC Filing
Form 144 Moderna, Inc. Filed by: Hoge Stephen
June 17, 2024 12:46 PM - SEC Filing
TD Cowen Reiterates Hold Rating on Moderna (MRNA)
June 14, 2024 7:46 AM - StreetInsider
Full Article List
